Considering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data
Abstract Low-dose computed tomography screening can be used to diagnose lung cancer at a younger age compared to no screening. Real-world studies observing mortality after lung cancer diagnosis are subject to lead-time bias. This study developed a method using a nationwide cancer registry and stage...
Enregistré dans:
Auteurs principaux: | , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ea58d8495bae47c98e5d171cf56cb00c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|